Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Sales (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Return on Sales for 16 consecutive years, with 0.12% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 12.0% to 0.12% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.13% for FY2025, 5.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.12% at Niagen Bioscience, down from 0.13% in the prior quarter.
  • The five-year high for Return on Sales was 0.25% in Q4 2024, with the low at 0.51% in Q3 2021.
  • Average Return on Sales over 5 years is 0.11%, with a median of 0.06% recorded in 2022.
  • The sharpest move saw Return on Sales fell -21bps in 2021, then skyrocketed 36bps in 2023.
  • Over 5 years, Return on Sales stood at 0.3% in 2021, then soared by 77bps to 0.07% in 2022, then soared by 108bps to 0.01% in 2023, then soared by 4483bps to 0.25% in 2024, then tumbled by -50bps to 0.12% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.12%, 0.13%, and 0.12% for Q4 2025, Q3 2025, and Q2 2025 respectively.